TITLE

Blood recipient notification for hepatitis C in Prince Edward Island

AUTHOR(S)
Van Til, LInda D.; Sweet, Lamont E.
PUB. DATE
January 2000
SOURCE
CMAJ: Canadian Medical Association Journal;1/25/2000, Vol. 162 Issue 2, p199
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
AbstractBackground: Two of the major risk factors for hepatitis C are injection drug use and receipt of blood or blood products. Many patients are unaware that they have received transfusions. In 1998 Prince Edward Island conducted a province-wide look-back notification program to notify patients who had received transfusions in PEI between Jan. 1, 1984, and June 1, 1990. The authors present the results of the notification program.Methods: A registry for recipients of blood and blood products was created from the province's Red Cross blood bank records. The registry data were linked with Vital Statistics data to determine death status and with Health Registration data to determine residence status of recipients (in PEI or moved out of province). All identified recipients with a current PEI mailing address were sent a letter recommending hepatitis C virus (HCV) testing. Laboratory records were checked to determine HCV test results.Results: The registry contained data for 6086 recipients of blood or blood products during the look-back period; 51.1% (3109/6086) had died by the time of notification. Of the remainder, 18.4% (549/2977) were not directly notified because they had moved out of province, had refused delivery of the notification letter or had died recently, or because identifying information was missing from the blood bank records. Of the recipients who were notified 80.4% (1953/2428) underwent testing, and 2.2% (43/1953) were found to be HCV positive. Most of these (58.1% [25/43]) had undergone testing before notification. The HCV positivity rate differed significantly between recipients tested before notification and those tested after notification (9.9% v. 1.1%, p < 0.001). HCV-positive recipients were more likely than other notified recipients to have had multiple transfusions (39.5% v. 9.5%, p < 0.001).Interpretation: Before notification 4.1% of PEI recipients had undergone HCV testing. After notification 91.2% of PEI recipients were identified as te...
ACCESSION #
2731198

 

Related Articles

  • Prevalence and Correlates of Hepatitis C Infection among Male Injection Drug Users in Detention, Tehran, Iran. Kheirandish, Parastoo; SeyedAlinaghi, SeyedAhmad; Jahani, MohammadReza; Shirzad, Hadi; Seyed Ahmadian, MohammadReza; Majidi, Ali; Sharifi, AmirHoushang; Hosseini, Mostafa; Mohraz, Minoo; McFarland, Willi // Journal of Urban Health;Dec2009, Vol. 86 Issue 6, p902 

    For the benefit of planning for the future care and treatment of people infected with hepatitis C virus (HCV) and to help guide prevention and control programs, data are needed on HCV seroprevalence and associated risk factors. We conducted a cross-sectional sero-behavioral survey of injection...

  • EMERGING EPIDEMIC. Querna, Betsy // U.S. News & World Report;3/13/2006, Vol. 140 Issue 9, p60 

    This article reports on the rise in the cases of hepatitis C. The disease causes no symptoms for years and many carriers are unaware they are infected. There is considerable stigma attached to the disease as infection can result from the use of dirty needles in drug abuse that may have occurred...

  • Determination of Hepatit C genotype and risk factors of transmission in Bushehr province 2008. Vahdat, K.; Amini, A.; Moatamed, N.; Eghbali, S. S.; Zandi, K.; Hajeiani, G. H. // Iranian South Medical Journal;2012, Vol. 15 Issue 1, p51 

    Background: Hepatitis C is one of the main causes of mortality and disability of liver diseases worldwide. Main transmission rout is blood transfusion and its epidemiology is changing due to increasing injecting drug users. It is also important because of co-transfer with HIV. In order to...

  • Findings from the Queensland Injecting Drug Survey (QuIDS): comparing hepatitis C risk behaviours among Indigenous and non-Indigenous people who inject drugs. Dev, Abhilash; Kemp, Robert; Ward, James; Henderson, Suzanna; Williams, Sidney; Smirnov, Andrew; Plotnikova, Maria; Najman, Jake M. // HIV Australia;Oct2013, Vol. 11 Issue 3, p37 

    The article presents the findings of the Queensland Injecting Drug Survey (QuIDS) which compares the risks behaviours for hepatitis C among indigenous and non-indigenous people who inject drugs in Queensland. It is inferred that the QuIDS was initiative in response to concerns about the increase...

  • Frequent Longitudinal Sampling of Hepatitis C Virus Infection in Injection Drug Users Reveals Intermittently Detectable Viremia and Reinfection. Page, Kimberly; Osburn, William; Evans, Jennifer; Hahn, Judith A.; Lum, Paula; Asher, Alice; Delwart, Eric; Tobler, Leslie; Cox, Andrea L.; Busch, Michael P. // Clinical Infectious Diseases;Feb2013, Vol. 56 Issue 3, p405 

    Defining clear hepatitis C virus (HCV) infection outcomes, including reinfection and viral intercalation after clearance of infection, requires ongoing, frequent follow-up, most importantly with longitudinal viral sequencing. Patients who have cleared HCV infection may demonstrate sustained...

  • Risk of hepatitis C infection among injection drug users in Mizoram, India. Chelleng, P. K.; Borkakoty, B. J.; Chetia, M.; Das, H. K.; Mahanta, J. // Indian Journal of Medical Research;Nov2008, Vol. 128 Issue 5, p640 

    Background & objectives: Prevalence of injection drug users (IDUs) is high in the northeastern region of India. This coupled with unsafe injecting practices as well as practice of tattooing in remote tribal areas call for baseline data on the prevalence of parentally transmitted viral diseases....

  • Agent-Based Model Forecasts Aging of the Population of People Who Inject Drugs in Metropolitan Chicago and Changing Prevalence of Hepatitis C Infections. Gutfraind, Alexander; Boodram, Basmattee; Prachand, Nikhil; Hailegiorgis, Atesmachew; Dahari, Harel; Major, Marian E. // PLoS ONE;09/30/2015, Vol. 10 Issue 10, p1 

    People who inject drugs (PWID) are at high risk for blood-borne pathogens transmitted during the sharing of contaminated injection equipment, particularly hepatitis C virus (HCV). HCV prevalence is influenced by a complex interplay of drug-use behaviors, social networks, and geography, as well...

  • Perception of hepatitis C risk among injecting drug users who obtain injecting equipment from pharmacies in Western Australia. WILSON, HANNAH; BRYANT, JOANNE // Contemporary Drug Problems;Winter2010, Vol. 37 Issue 4, p599 

    No abstract available.

  • Syringe Exchange and Risk of Infection with Hepatitis B and C Viruses. Hagan, Holly; McGough, James P.; Thiede, Hanne; Weiss, Noel S.; Hopkins, Sharon; Alexander, E. Russell // American Journal of Epidemiology;1999, Vol. 149 Issue 3, p203 

    The authors utilized a cohort study among Seattle injection drug users (IDUs) to assess whether participation in a syringe exchange program was associated with incidence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection. Susceptible IDU subjects (187 seronegative for antibody to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics